⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Newport Pharmaceuticals of Costa Rica S.A. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Newport Pharmaceuticals of Costa Rica S.A.
↗San José, Costa Rica
Newport Pharmaceuticals is a pharmaceutical company based in San José, Costa Rica. It is known for the production and distribution of pharmaceutical products, most notably the brand Isoprinosine, which is marketed in over 80 countries.
The company focuses on pharmaceutical innovation and wellness, maintaining operations in the Latin American market. It is distinct from the U.S.-based Newport Corporation (a photonics/technology company acquired by MKS Instruments).
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Manufacturing
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various international distributors for Isoprinosine
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Luis Ordeñana Castro - VP of New Business
LINKS
Website:newportcorp.net
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Newport Pharmaceuticals of Costa Rica S.A.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.